July 26, 2010 – Today a fourth-generation intracranial aneurysm stent
system was released in both the U.S. and European markets. Boston Scientific’s Neuroform EZ Stent System is designed for use in conjunction with endovascular coiling to treat wide-necked aneurysms.
The stent is engineered to provide flexibility and conformability, especially in tortuous brain anatomy. It employs Boston Scientific’s proprietary Segmental Expansion technology, designed to enhance stent anchoring and stability. The product features the proven hybrid cell design of prior-generation Neuroform Stents while incorporating a simplified, single-operator delivery system intended to facilitate preparation, delivery and positioning of the stent.
The first Neuroform EZ Stent was implanted in the United States by Demetrius Lopes, M.D., of the Rush University Medical Center in Chicago, and the first European procedure was performed by professor Laurent Spelle, M.D., Ph.D., at Foundation Rothschild Hospital, Beaujon School of Medicine in Paris.
“The Neuroform EZ Stent System performed well in a very challenging first procedure,” Lopes said. “The smooth transfer of the stent into the catheter, combined with excellent support, stability and visibility, facilitated accurate stent placement.”
“The improved delivery system of the Neuroform EZ Stent helped me to place the stent exactly where I planned,” said Spelle. “In my experience, Boston Scientific’s new system is easier to use compared to its previous microdelivery system and should offer benefits for both physicians and patients.”
Boston Scientific will demonstrate its Neuroform EZ Stent System at the 7th Annual Society of NeuroInterventional Surgery (SNIS) Meeting, July 26–30 in Carlsbad, Calif.
For more information: www.bostonscientific.com
October 16, 2024 
